They showed that the anti-proliferative and pro-apoptotic agent nutlin-3 resulted in a p53-dependent increase of NOTCH1 mRNA and protein levels in CLL cells. This evidence concerns the gene TP53 and B-cell chronic lymphocytic leukemia.